Am J Psychiatry 157:185-189, February 2000
© 2000 American Psychiatric Association
Paroxetine in Human Breast Milk and Nursing Infants
Zachary N. Stowe, M.D.,
Lee S. Cohen, M.D.,
Amy Hostetter, B.A.,
James C. Ritchie, Ph.D.,
Michael J. Owens, Ph.D., and
Charles B. Nemeroff, M.D., Ph.D.
OBJECTIVE: The purpose of this study was to determine the extent of infant medication exposure through breast-feeding during maternal treatment with paroxetine. METHOD: Breast milk and paired maternal and infant sera were collected after 10 days of maternal treatment with paroxetine at a stable daily dose (10–50 mg/day). All samples were analyzed by means of high-performance liquid chromatography with ultraviolet detection and a limit of detection of 2 ng/ml. RESULTS: Breast milk paroxetine concentrations were highly variable (2–101 ng/ml) and were present in all breast milk samples (N=108). A significant gradient effect was observed, with greater paroxetine concentrations found in later portions of breast milk (hind milk) than in early portions (fore milk). No clear time course of paroxetine excretion into breast milk was demonstrated, although maternal paroxetine daily dose reliably predicted both trough and peak breast milk concentrations over a 24-hour period. In 16 mother and infant serum pairs, no detectable concentrations of paroxetine were found in the serum of the nursing infants. CONCLUSIONS: This study extends previous data by demonstrating the presence of paroxetine in the breast milk of nursing women treated with this medication. The low concentrations of paroxetine in infant serum and lack of any observable adverse effects after maternal use of this medication while breast-feeding parallels the available data on other selective serotonin reuptake inhibitors.
This article has been cited by other articles:
|
|
|
|
 
D. J. Newport, P. B. Pennell, M. R. Calamaras, J. C. Ritchie, M. Newman, B. Knight, A. C. Viguera, J. Liporace, and Z. N. Stowe
Lamotrigine in Breast Milk and Nursing Infants: Determination of Exposure
Pediatrics,
July 1, 2008;
122(1):
e223 - e231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Loughhead, A. D. Fisher, D. J. Newport, J. C. Ritchie, M. J. Owens, C. L. DeVane, and Z. N. Stowe
Antidepressants in Amniotic Fluid: Another Route of Fetal Exposure
Am J Psychiatry,
January 1, 2006;
163(1):
145 - 147.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W. Hale
Pharmacology Review: Drug Therapy and Breastfeeding: Antidepressants, Antipsychotics, Antimanics, and Sedatives
NeoReviews,
October 1, 2004;
5(10):
e451 - e456.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Weissman, B. T. Levy, A. J. Hartz, S. Bentler, M. Donohue, V. L. Ellingrod, and K. L. Wisner
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
Am J Psychiatry,
June 1, 2004;
161(6):
1066 - 1078.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gjerdingen
The Effectiveness of Various Postpartum Depression Treatments and the Impact of Antidepressant Drugs on Nursing Infants
J Am Board Fam Med,
September 1, 2003;
16(5):
372 - 382.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. J. Begg, S. B. Duffull, L. P. Hackett, and K. F. Ilett
Studying Drugs in Human Milk: Time to Unify the Approach
J Hum Lact,
November 1, 2002;
18(4):
323 - 332.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. M. Costei, E. Kozer, T. Ho, S. Ito, and G. Koren
Perinatal Outcome Following Third Trimester Exposure to Paroxetine
Arch Pediatr Adolesc Med,
November 1, 2002;
156(11):
1129 - 1132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Hendrick and L. Altshuler
Management of Major Depression During Pregnancy
Am J Psychiatry,
October 1, 2002;
159(10):
1667 - 1673.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Wisner, B. L. Parry, and C. M. Piontek
Postpartum Depression
N. Engl. J. Med.,
July 18, 2002;
347(3):
194 - 199.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. HENDRICK, L. ALTSHULER, A. WERTHEIMER, and W. A. DUNN
Venlafaxine and Breast-Feeding
Am J Psychiatry,
December 1, 2001;
158(12):
2089 - 2090.
[Full Text]
|
|
|
|
|
|
|
C. B. Nemeroff
Progress in the Battle With the Black Dog: Advances in the Treatment of Depression
Am J Psychiatry,
October 1, 2001;
158(10):
1555 - 1557.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Epperson, K. A. Czarkowski, D. Ward-O'Brien, E. Weiss, R. Gueorguieva, P. Jatlow, and G. M. Anderson
Maternal Sertraline Treatment and Serotonin Transport in Breast-Feeding Mother-Infant Pairs
Am J Psychiatry,
October 1, 2001;
158(10):
1631 - 1637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Committee on Drugs
The Transfer of Drugs and Other Chemicals Into Human Milk
Pediatrics,
September 1, 2001;
108(3):
776 - 789.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. HENDRICK, A. FUKUCHI, L. ALTSHULER, M. WIDAWSKI, A. WERTHEIMER, and M. V. BRUNHUBER
Use of sertraline, paroxetine and fluvoxamine by nursing women
The British Journal of Psychiatry,
August 1, 2001;
179(2):
163 - 166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Burt, R. Suri, L. Altshuler, Z. Stowe, V. C. Hendrick, and E. Muntean
The Use of Psychotropic Medications During Breast-Feeding
Am J Psychiatry,
July 1, 2001;
158(7):
1001 - 1009.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. L. WISNER, R. L. FINDLING, and J. M. PEREL
Paroxetine in Breast Milk
Am J Psychiatry,
January 1, 2001;
158(1):
144- - 144.
[Full Text]
|
|
|
|
|
|
|
Nursing Infants and Paroxetine Exposure
Journal Watch Psychiatry,
March 1, 2000;
2000(301):
1 - 1.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
